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Abstract 1 
Our ability to rescue functional deficits after demyelinating diseases or spinal cord injuries is 2 
limited by our lack of understanding of the complex remyelination process, which is crucial to 3 
functional recovery. In this study, we developed an electrospun suspended poly(ε-caprolactone) 4 
microfiber platform to enable the screening of therapeutics for remyelination. As a proof of concept, 5 
this platform employed scaffold-mediated non-viral delivery of a microRNA (miR) cocktail to 6 
promote oligodendrocyte precursor cells (OPCs) differentiation and myelination. We observed 7 
enhanced OPCs differentiation when the cells were transfected with miR-219 and miR-338 on the 8 
microfiber substrates. Moreover, miRs promoted the formation of MBP+ tubular extensions around 9 
the suspended fibers, which was indicative of myelination, instead of flat myelin membranes on 2D 10 
substrates. In addition, OPCs that were transfected with the cocktail of miRs formed significantly 11 
longer and larger amounts of MBP+ extensions. Taken together, these results demonstrate the 12 
efficacy of this functional screening platform for understanding myelination. 13 
 14 
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1. Introduction 1 
Oligodendrocytes (OLs), an important class of glia, are the myelinating cells of the central 2 
nervous system (CNS). Myelination, the process by which OLs form multiple multilamellar sheaths 3 
around axons, allows rapid sensory-motor coordination in vertebrates. As such, pathological loss of 4 
myelin, or demyelination, impairs function due to disrupted action potential propagation as seen in 5 
Multiple Sclerosis (MS) and spinal cord injuries (SCI). 6 
 7 
Remyelination restores myelin sheaths to demyelinated axons to reinstate salutatory 8 
conduction by following a sequence of events in a precise and temporally controlled fashion [1]. 9 
Following oligodendrocyte precursor cells (OPCs) activation and recruitment, OPCs differentiate into 10 
OLs and ensheath axons (i.e. nascent myelin sheaths) before compacting into multilamellar myelin 11 
sheaths (i.e. mature myelin wraps) [1-4]. However, these final stages of remyelination often fail to 12 
transpire in MS and SCI [1]. The functional loss associated with failure in remyelination has 13 
prompted the search for better therapeutics. Yet, the development of therapeutic strategies for 14 
remyelination has been largely hindered by our lack of understanding of the intricate differentiation 15 
and myelination processes. Hence, in vitro platforms that allow us both to study these processes and 16 
at the same time enable functional screening of promising pro-myelinogenic therapeutics are highly 17 
valuable [5].  18 
 19 
Among the various stages that are involved in OPC differentiation, maturation and 20 
myelination, the first two steps of differentiation and maturation of OPCs are often analyzed by 21 
fairly straightforward immunohistochemical evaluations of specific OL markers such as CNPase, 22 
Myelin Basic Protein (MBP) and others [6-9]. However, the main functionality of an OL is determined 23 
at the final stage of myelination, where radial and longitudinal growths of myelin wraps occur [10]. 24 
 4 
Unfortunately, this final stage of myelination remains highly challenging to model in an in vitro 1 
culture. Yet it is crucial to achieve robust aforementioned growth of myelin wraps to enable the 2 
systematic examination of OL functionality and screening of therapeutics that can modulate 3 
remyelination. 4 
 5 
By mimicking the size scale and architecture of axons, electrospun fibers have been utilized 6 
to replace neurons in conventional neuron-OL co-cultures for studies on myelination. This strategy 7 
helps to remove influences of axonal signalling and reveals the intrinsic myelination capabilities of 8 
OL in response to physical signals [11, 12]. While platforms comprising of dense electrospun fiber 9 
mesh provide axon-mimicking physical cues to support OL myelination, it is difficult to do direct 10 
imaging and quantification of the myelin [8, 9]. On the contrary, the sparse fiber platforms that were 11 
engineered previously do not provide suspended fibers to prevent OPCs from sensing the stiff 12 
underlying supporting substrate [13]. Moreover, the role of biochemical signalling is also crucial. Yet, 13 
such a biofunctional axon-like substrate remains unavailable for probing the effects of potential 14 
biochemical signals on myelination. 15 
 16 
Here, we introduce a simple and versatile method to biofunctionalise microfiber scaffolds to 17 
allow controlled and sustained delivery of promyelinogenic biomolecules to OPCs. This platform is 18 
comprised of suspended-axon-mimicking fibers, which supports OL myelination. As compared to 19 
conventional electrospun membranes, this platform also allows straightforward visualization of 20 
myelination. We show that using the versatile mussel-inspired bioadhesive, polydopamine (PD), 21 
coating, these axon-like fibers could be easily functionalized with drugs to serve as a reservoir for 22 
sustained drug/gene delivery. Correspondingly, such scaffolds not only serve as potential drug/gene 23 
screening platforms for identifying important promyelinogenic therapeutics but can also be easily 24 
 5 
translated into direct implantable devices for future in vivo regeneration and remyelination purposes 1 
[14].  2 
As a proof-of-concept, we delivered a cocktail of microRNA (miR) mimics using this platform 3 
to control, visualize and quantify OL differentiation and myelination. In particular, miR-219 and miR-4 
338 are potent post-transcriptional regulators that are involved in OPC development [15, 16]. We 5 
previously showed that these miRs act synergistically to down-regulate the expression of inhibitors 6 
of OPCs differentiation and promoted OPCs differentiation and maturation [8, 9]. More recently, 7 
further evidence also suggests that the two miRs act in tandem to promote myelination [17]. Thus, 8 
we hypothesized that PD fiber-mediated delivery of miR-219 and miR-338 will promote OPC 9 
differentiation and myelination, which can be evaluated and quantified using our suspended 10 
biofunctional, axon-mimicking microfiber platform.  11 
 12 
2. Materials and Methods 13 
2.1 Materials 14 
 Polycaprolactone (PCL, Mw: 200,000) was purchased from PolySciTech. Polycaprolactone 15 
(PCL, Mw: 45,000), 2,2,2-trifluoroethanol (TFE), dopamine hydrochloride, Dnase 1 type IV, Poly-D-16 
Lysine (PDL), N-Acetyl-L-Cysteine (NAC), D-biotin, ITS, Putrescine, L-Thyroxine (T4), Tri-iodothyronine 17 
(T3), Progesterone, Bovine Serum Albumin (BSA), L-cysteine, Triton X-100 were purchased from 18 
Sigma-Aldrich. Scramble negative control miR, miR-219, miR-338-3p, miR-338-5p mimics, Alexa-Fluor 19 
488 goat anti-rat, Alexa-Fluor 633 goat anti-rabbit antibodies, minimum essential media (MEM), 20 
DMEM High Glucose, Penicillin/Streptomycin (Pen/Strep) were purchased from Life Technologies. 21 
NS21 supplement and Neuro Medium were purchased from Miltenyi Biotech. TransIT-TKO was 22 
purchased from MirusBio. Rat anti-Myelin Basic Protein (MBP, aa82-87) was purchased from Bio-Rad. 23 
 6 
Rabbit anti-Oligodendrocyte Transcription Factor 2 (Olig2, AB9610) was purchased from Merck. 1 
Papain suspension was purchased from Worthington. 2 
 3 
2.2 Fabrication and characterisation of suspended microfiber substrate 4 
Figure 1A illustrates the engineering of the suspended microfiber platform. PCL pellets (MW: 5 
45,000) were melted on a hot plate in a mould and allowed to cool and solidify into a block of PCL. 6 
Following that, the block was embedded into optimal cutting temperature medium (OCT) and 7 
cryosectioned into 20 μm films, which were then dried in a 37 oC oven. Two dried pieces of PCL films 8 
were then placed at two opposing ends of a 15-mm diameter glass coverslip at a distance of 0.5 cm 9 
apart and melted briefly on a hotplate at about 50 °C. These glass coverslips were then pasted onto 10 
a rotating wheel with carbon tape. For electrospinning of microfibers, PCL (MW: 200,000) was 11 
dissolved in TFE to make a 7 wt% solution. Thereafter, the homogeneous solution was loaded into a 12 
syringe and dispensed at a fixed rate of 2 ml/h by a syringe pump (New Era pump system Inc., USA) 13 
through a 22G needle. Positive 4 kV and -4 kV voltages (Gamma High Voltage, USA) were then 14 
applied to the needle and rotating collector (730 rpm) respectively. The distance between the 15 
needle and the collector was kept at 11.5 cm. After the fibers were collected, PCL films were melted 16 
briefly again to allow the fibers to stick to the PCL films. Since the melted films may cause fibers to 17 
slack and sink to the glass coverslips, to check if the fibers remained taut and suspended after the 18 
process, we repeated the melting and collection processes 3 times. Thereafter, the dried suspended 19 
microfiber scaffolds were secured by applying a layer of silicon glue around the circumference of 20 
each coverslip.  21 
For 3-dimensional (3D) imaging of myelin, di(thiophene-2-yl)-diketopyrrolopyrrole 22 
conjugated PCL (PCL-DPP-PCL) fluorescent fibers were prepared according to previously reported 23 
protocol [18]. Briefly, to ensure similar fiber diameter as plain PCL fibers, PCL was mixed with 1 wt% 24 
 7 
of PCL-DPP-PCL in TFE to make a 12.5 wt% solution. Thereafter, the solution was dispensed at a flow 1 
rate of 1.5 ml/h through a 21G needle for electrospinning. The collector was located 12 cm away and 2 
rotated at 1500 rpm. Positive 12 kV and negative 4 kV voltages were applied on the needle and 3 
collector respectively. 4 
 5 
2.3 Scanning electron microscopy 6 
The morphology of the microfibers was evaluated using scanning electron microscopy (SEM) 7 
(JEOL, JSM-6390LA, Japan). Briefly, PCL substrates were attached onto the SEM support by carbon 8 
tapes and sputter-coated with platinum for 60 s at 20 mA.  Thereafter, the samples were imaged 9 
under an accelerating voltage of 10 kV. 10 
 11 
2.4 Preparation of miR-loaded fibers 12 
The microfiber substrates were sterilised and wetted with 70% ethanol for 15 min. The 13 
substrates were then incubated in 1 ml of 0.5 mg/ml dopamine hydrochloride solution for 4 h on an 14 
orbital shaker to form the polydopamine (PD) coating. After 3 washes with DI water, the fibers were 15 
further coated with 2 ml of 5 μg/ml PDL overnight and washed 3 times with DI water. For miR 16 
adsorption, 2 μg of miR was complexed at 1:1 v/v ratio with the transfection reagent, TKO. The 17 
amount of miR and its ratio with TKO have been optimised for high gene silencing and low cellular 18 
toxicity based on our previous works [8, 9]. Specifically, 3 μl of 50 μM miR was complexed with 3 μl 19 
of TKO for 15 min in 100 μl of DMEM. The complex was then added onto the PDL coated fibers and 20 
incubated at 37 oC for an hour. All substrates were divided into two groups: TKO with scrambled 21 
Negative Control miR (NEG miR control); and TKO with equal masses of miR-219, miR-338-3p and 22 
 8 
miR-338-5p (miR-219/miR-338). Substrates that were not used for the delivery of miRs were coated 1 
with 5 μg/ml of PDL overnight and washed 3 times with DI water before cell seeding. 2 
 3 
2.5 OPCs isolation and myelination culture 4 
The isolation of primary OPCs from rats was approved by the Institutional Animal Care and 5 
Use Committee (IACUC) at Nanyang Technological University, Singapore. The isolation and culture of 6 
primary OPCs and the myelination culture were carried out according to two previously reported 7 
protocols [12, 19]. Briefly, P0-P2 neonatal rat cortices that were cleaned from meninges were 8 
enzymatically digested with 1.2 U Papain and 40 μg/ml DNase at 37 oC for 1 h. Thereafter, the 9 
enzymatic activity was stopped with 8 ml of DMEM with 10% Fetal Bovine Serum (FBS) and the 10 
dissociated tissues were triturated with a 21G needle and syringe. Tissues from 6 digested cortices 11 
were seeded onto 4 PDL-coated T75 flasks and cultured in DMEM with 10% FBS and 1% Pen/Strep. 12 
After 9-11 days, the OPCs were separated from the mixed glia culture by shaking on an orbital 13 
shaker at 200 rpm for 1 h at 37 oC to remove the loosely attached microglia. This was followed by a 14 
further 16-17 h of shaking. OPCs were then further purified by differential adhesion on untreated 15 
petri dishes for 25 min. Through this isolation method, the purity of the OPCs attained was 95.3 ± 16 
1.6 % (Supplementary Figure 1). Purified OPCs were then seeded at a density of 35,000 onto each 17 
suspended fiber substrate, and cultured for 7 days in myelin medium, which consisted of 18 
DMEM:Neurobasal (50:50), NS21, 1% Pen/Strep, Glutamax, ITS, 10 ng/ml biotin, 5 μg/ml NAC and 19 
SATO (100 μg/ml BSA, 60 ng/ml Progesterone, 16 μg/ml Putrescine, 400 ng/ml T3 and T4). 20 
 21 
2.6 Immunofluorescent staining 22 
 9 
After 7 days, the cultures were fixed with 4% paraformaldehyde (PFA). The fixed myelin-fiber 1 
cultures were then permeabilised with 0.1% Triton-X for 15 min at room temperature. Next, the 2 
samples were incubated with primary antibodies overnight at 4 oC, followed by secondary antibodies 3 
for 1 h at room temperature. The primary antibodies used were: rat anti-MBP (1:200) and rabbit 4 
anti-Olig2 (1:1000). The secondary antibodies used were: Alexa-Fluor 488 goat anti-rat and Alexa 5 
Fluor 633 goat anti-rabbit (both at 1:1000). The nuclei were counterstained with DAPI. The samples 6 
were then mounted onto 60 mm coverglass with Fluoromount-G and imaged under a Zeiss LSM 800 7 
confocal microscope.  8 
 9 
To calculate the percentage of MBP+ cells with respect to DAPI (MBP+/DAPI), 10 non-10 
overlapping regions of interest (ROI) were chosen randomly for each substrate at 20x magnification. 11 
The percentages of MBP+/DAPI were then calculated by (number of MBP+ cells/number of DAPI) x 12 
100% with an average of more than 140 DAPI+ cells counted for each group per experiment. The 13 
percentages of MBP+ cells with respect to OLIG2 (MBP+/OLIG2+) were computed by counting on an 14 
average of more than 110 OLIG2+ cells from each group and using the formula: (number of MBP+ 15 
cells/number of OLIG2+ cells) x 100%. The experiment was repeated 3 times, resulting in the analysis 16 
of a total of more than 420 DAPI+ and 330 OLIG2+ cells per sample group. 17 
 18 
To calculate the percentage of MBP+ cells with myelin-like extensions/wrappings on fibers 19 
only, MBP+ structures were thoroughly examined by looking at the entire z-layer (step size 0.75 μm) 20 
to observe any membrane formation on fibers and/or coverglass at 20x magnification. MBP+ cells 21 
that formed membranes on fibers but not on cover glass were qualified as “MBP+ cells with only 22 
myelin-like extensions on fibers”. The percentage of MBP+ cells with myelin-like extensions on fibers 23 
only was computed by (number of MBP+ cells with only myelin-like extension on fibers only/total 24 
 10 
number of MBP+ cells) x 100%. On average more than 50 MBP+ cells were evaluated from at least 10 1 
ROI per substrate for each group. The experiment was repeated 3 times. 2 
 3 
A myelin-like extension was defined as a continuous tube of MBP staining that stretched 4 
along a fiber. To measure the length of myelin-like extensions on fibers, MBP signals from single 5 
DAPI were traced along individual fibers at 40 x magnification. The measured lengths were then 6 
plotted in logarithmic scale as “log(nascent sheath length)”. Gaussian distribution was then used to 7 
fit the distribution of log(nascent sheath length) for average length comparison [12]. On average 30 8 
myelin-like wrappings were measured per experiment, resulting in a total of 196 nascent sheaths 9 
being quantified in all 3 experimental repeats. To compute for the number of nascent myelin 10 
sheaths per cell, 35 MBP+ cells in the miR-219/miR-338 group and 30 MBP+ cells in the negative miR 11 
(NEG miR) group from 3 independent experiments were included in the analysis. All measurements 12 
were done using the Fiji version of ImageJ [20]. 13 
 14 
2.7 Statistical analysis 15 
All values were presented as mean ± standard error of mean (S.E.M). Student’s t-test was 16 
used to compare between NEG miR control and the miR-219/miR-338 group. P-values of less than 17 
0.05 were considered to be statistically significant. 18 
 19 
3. Results 20 
3.1 Characterisation of suspended PCL microfiber substrates 21 
 11 
Figure 1A illustrates the engineered suspended-microfiber substrate. The average diameter 1 
of the microfibers was 2.0 ± 0.3 μm, a diameter that is known to be permissive for myelination 2 
(Figure 1B) [12, 13]. Supplementary Figure 2 shows that the fibers remained taut and suspended 3 
even after 3 layers of PCL films were repeatedly melted and 3 layers of PCL fibers were deposited 4 
after each melting. 5 
 6 
Figure 1C shows that OPCs differentiated into MBP+ OLs and appeared to ensheath the 7 
microfiber substrates in the absence of miRs. Multiple MBP+ extensions that were indicative of 8 
nascent myelination were formed by OLs, as shown by the bright green MBP signals. These myelin-9 
like extensions ran along the electrospun fibers, as shown in Supplementary Figure 3. PCL-DPP-PCL 10 
fibers fluoresce brightly at 568 nm wavelength upon excitation while green MBP signals ran in 11 
conjunction. Supplementary Figure 3B shows a confocal 3D reconstruction view of an OL on the red 12 
PCL-DPP-PCL fibers. Tubes of MBP signals were seen around red fibers, confirming MBP+ 13 
ensheathment of fibers by the OL. In the absence of growth factors, some OPCs underwent 14 
apoptosis after 7 days in culture as indicated by the abnormally small and bright spots of DAPI 15 
staining (Figure 1C). Concurrently, Olig2 expression was not detectable in these cells. Nonetheless, 16 
the results suggest that this platform could support the formation of myelin-like extensions on the 17 
suspended microfibers. 18 
 19 
3.2 Scaffold-mediated miR-219 / miR-338 delivery promoted OPC differentiation in the 20 
absence of mitogen 21 
OPCs remained viable and differentiated into MBP+ OLs on PD-PDL coated substrates after 22 
transfection with miRs. Figure 2A shows that purified OPCs differentiated into OLIG2 and MBP 23 
expressing OLs on the miR-adsorbed platforms. In particular, a higher percentage of MBP+ OLs was 24 
 12 
seen with miR-219 and miR-338 treatment. Thus, miR cocktail promoted OPC differentiation in a 1 
pro-differentiation, mitogen-free environment. Specifically, a 1.42-fold and 1.40-fold increase in the 2 
percentage of MBP+ cells were observed when normalized against DAPI and OLIG2 respectively, 3 
when the OPCs were transfected with 2 μg of miR cocktail (p < 0.05, Figure 2B and Figure 2C). The 4 
results show that miR-219 and miR-338 acted in synergy with the myelination medium and further 5 
promoted the differentiation and maturation of OPCs. 6 
 7 
3.3 Scaffold-mediated miR-219 / miR-338 delivery promoted the formation of myelin-like 8 
extensions on fiber 9 
 In our platform, PCL fibers were suspended at a distance of about 20 μm above the glass 10 
coverslip surface using PCL films. The low fiber density allowed OPCs to pass through the gaps 11 
between electrospun fibers and adhere to the coverslip while maintaining contact with the 12 
suspended fibers. As OPCs were in contact with both 2D and 3D substrates, they were able to form 13 
both flat membranes on the cover-glass and myelin processes that tracked along or partially covered 14 
the fibers as they differentiated into OLs (Figure 3A). 15 
 16 
 As shown in Figure 3B, OLs preferred to form MBP+ extensions or nascent myelin sheaths 17 
along the axon-mimicking fibers when they were treated with the cocktail of miRs. Specifically, miR-18 
219 / miR-338 treatment induced 2.9-fold more MBP+ cells forming only myelin-like wrappings on 19 
fibers (p < 0.01, Figure 3C). On the other hand, OLs that were subjected to Neg miR treatment 20 
(Control group) had an inclination towards forming both MBP+ extensions or nascent myelin sheaths 21 
on fibers and myelin membranes on coverglass, or myelin membranes only (Figure 3A). Thus, miR-22 
219 / miR-338 enhanced the interaction of OPCs with 3D axon-like substrates, suggesting that 23 
biomolecules could alter cellular response towards physical cues. 24 
 13 
 1 
3.4 Scaffold-mediated miR-219 / miR-338 delivery promoted longer fiber ensheathment 2 
 Substrate-mediated delivery of miRs increased the length of fiber ensheathment by OLs on 3 
the substrates (Figure 4 and Supplementary Figure 4). In the presence of miR-219 and miR-338, OLs 4 
formed significantly longer nascent myelin sheaths around the suspended fibers (Figure 4A and 5 
Supplementary Figure 4A for miR-219 / miR-338, Supplementary Figure 4B for NEG miR). 6 
Quantification results as illustrated in Figure 4B shows that the distribution of the length of fiber 7 
ensheathment shifted towards a larger value when the cells were treated with the miR cocktail. 8 
Specifically, 1.94-fold longer nascent myelin sheaths were formed by the OLs when they were 9 
treated with the cocktail of miR-219 / miR-338 (Figure 4C). 10 
 11 
3.5 Scaffold-mediated miR-219 / miR-338 delivery promoted the formation of more myelin-12 
like extensions per cell 13 
 OLs formed multiple myelin-like extensions along multiple fibers on the substrates. This 14 
attribute of OLs was altered by substrate-mediated delivery of miRs. In particular, miR-219 and miR-15 
338-treated OLs had a higher number of myelin-like extensions being formed by each cell (Figure 5A). 16 
Specifically, miR-219 and miR-338-treated group had on average of 8.69 myelin extensions per OL as 17 
compared to 4.77 in the NEG miR treated group (p < 0.01, Figure 5B). Thus, both sheath number and 18 
length that were formed by individual OLs were enhanced on this substrate by substrate-mediated 19 
non-viral delivery of miR-219 / miR-338. 20 
 21 
4. Discussion 22 
 14 
 OLs are known to not require dynamic axonal signalling to initiate myelination [21]. Hence, 1 
microfibers, micropillars and microbeads have been engineered to uncouple the axon-OL crosstalk 2 
and provide biophysical cues for myelination studies [5, 11, 22]. While bolus supplementation of 3 
biomolecules could provide the necessary biochemical signals for cells on the aforementioned 4 
substrates, integrating biomolecules into tissue-engineered scaffolds could better recapitulate the in 5 
vivo microenvironment, which is known to impact OLs behaviour [23]. Thus, we developed a surface- 6 
functionalized platform to evaluate myelination using mussel-inspired PD coating.  7 
 8 
 OL differentiation and myelination are two different stages of OPC development with 9 
distinctive mechanisms [24]. In our previous work, our fiber mesh-mediated miR delivery platform 10 
promoted the differentiation and maturation of NG2+ OPCs into RIP+ and MBP+ cells with high 11 
viability [8, 9]. However, robust myelination in vitro requires optimisation of culture conditions and 12 
scaffold design for optimal biochemical and physical signaling. Moreover, the new platform should 13 
enable simple visualization, imaging and quantification of the extent of myelination. Thus, we 14 
engineered a low fiber density, axon-mimicking drug delivery model, specifically for these purposes. 15 
A low fiber density platform allows straightforward confocal imaging and quantification of myelin. 16 
With this, we were able to demonstrate physiologically-relevant myelin membrane extension by 17 
amalgamating physical cues from the low-density microfibers and biochemical signalling from the 18 
miR-219 / miR-338 cocktail (Figure 1, 4-5). 19 
 20 
PD-coated suspended microfiber substrates enabled effective surface adsorption of miRs 21 
without altering the topography of the electrospun fibers. These miRs could then be released in a 22 
sustained fashion and provide surface-mediated signalling, as shown in our previous studies [8, 9, 25, 23 
26]. Conventional siRNA or miRNA studies employ bolus transfection, where cells are exposed to 24 
 15 
RNAs transiently. However, sustained delivery of RNA complexes can have significantly better gene 1 
silencing efficiency than bolus transfection, which can be translated to more efficient OPC 2 
differentiation and maturation [9]. Furthermore, surface-adsorbed RNAs that were not released 3 
could be directly internalised by OPCs [26]. This mimics axon-OL biochemical signalling and further 4 
asserts the physiological relevance of our platform. All in all, we showed that substrate-mediated 5 
miR delivery enhanced OPC differentiation and membrane extension on our platform (Figure 2-5). 6 
Moreover, we have previously employed similar electrospun substrates for the delivery of proteins 7 
and low molecular weight drugs [27-29]. Thus, this microfiber substrate could be a versatile 8 
functional drug/gene screening platform for OLs. 9 
 10 
In our previous study, we employed a similar platform to knock down RE-1 Silencing 11 
Transcription Factor (REST) in mesenchymal stem cells (MSCs) using siRNA to enhance neuronal 12 
differentiation [25]. While we observed pro-neuronal differentiation effect of siREST when MSCs 13 
were subjected to conditions that were non-specific and suboptimal for such differentiation, the 14 
advantage of siREST was not seen when optimal neuronal differentiation condition was employed 15 
[25]. The results suggested that the gene silencing of REST was effective only in non-specific 16 
differentiation conditions. In contrast, miR-219 and miR-338 appeared to act in synergy with pro-17 
myelinogenic culture conditions. miR-219 and miR-338 have been elucidated to be the key miRs that 18 
are involved in OL maturation. These two miRs suppress critical inhibitory genes of OPC 19 
differentiation and myelination (PDGFRα, Sox6, FoxJ3, ZFP238) or inhibitory signalling pathways 20 
(NOTCH, LINGO) [6, 17]. Specifically, platelet-derived growth factor (PDGF) and fibroblast growth 21 
factor (FGF) are well known mitogenic factors. Their removal from culture medium results in the 22 
rapid differentiation of OPCs into OLs in vitro.  All previous in vitro experiments that analyzed the 23 
efficacy of miR-219 and miR-338 on directing OL differentiation utilized PDGF and FGF supplemented 24 
culture media [6, 8, 9]. Under such proliferative conditions, miR-219 / miR-338 promoted OPC 25 
 16 
differentiation into MBP+ OLs. In contrast, we employed myelin-promoting medium in this study, 1 
which comprised of a defined medium with no OPC mitogenic factors. Correspondingly, we showed 2 
for the first time that miR-219 and miR-338 could significantly promote OPC differentiation into 3 
mature MBP+ OLs, even in such mitogen-free, pro-differentiation environment (Figure 2). This 4 
suggests that miR-219 and miR-338 are potent factors in controlling OPC cell fate. 5 
 6 
OPCs cultured on 2-dimensional (2D) glass coverslips or culture dishes form flat myelin 7 
membrane sheets on the glass or plastic surface as they differentiate and mature into OLs [30]. On 8 
the other hand, OLs cultured on suspended fibers formed only myelin-like wrappings around the 9 
fibers [12]. In our platform, we observed an interesting phenomenon where scaffold-mediated 10 
delivery of miR-219 and miR-338 promoted the formation of only MBP+ extensions on fibers (Figure 11 
3). The inclination to form structures that are indicative of myelin sheaths by wrapping around the 12 
fibers rather than spreading membranes on the glass surface could be a pro-myelination indicator. 13 
Future studies could elucidate the mechanistic differences between flat myelin membrane and 14 
myelin sheath formation by OLs under the influence of miR-219/miR-338. In addition, ultrastructural 15 
analyses using transmission electron microscopy could also provide useful insights into the effects of 16 
miR-219/miR-338 on the integrity and structure of the formed myelin.  17 
 18 
Although in vitro CNS myelin sheath length is an intrinsic property of OL [12], this 19 
“myelinogenic potential” [31] of OL can be influenced by the underlying substrates. Firstly, 20 
substrates can alter this potential by activating signalling molecules through a surface receptor. 21 
Specifically, coating fiber substrates with laminin to reconstruct physiological OL-ECM interactions 22 
promoted the formation of significantly more myelin sheaths per OL [12]. In this work, we presented 23 
distinctive mechanism on how substrates could also be employed to deliver molecules into 24 
 17 
OPCs/OLs and remodel their myelinogenic potential. Specifically, our substrate-mediated delivery of 1 
miR-219 and miR-338 changed how OLs spread their membranes on glass or fibers (Figure 3-5). The 2 
diverse mechanisms underlined the versatility of electrospun substrates in controlling myelination 3 
and reinforced the notion that our microfiber-substrate could serve as an effective functional testing 4 
platform for OL myelination. 5 
 6 
Apart from serving as an in vitro platform for understanding myelination, electrospun fibers 7 
may also be designed into directly implantable substrates for in vivo nerve regeneration applications, 8 
such as in the case of spinal cord injury treatment [14]. In particular, the biomimicking topography of 9 
electrospun fibers provides contact guidance to nerve regeneration while the sustained delivery of 10 
drugs and genes from these scaffolds offers synergistic biochemical signaling to direct cell fate and 11 
tissue regrowth [14]. Thus, promising drugs or genes as assessed on these fiber platforms may be 12 
directly translated to in vivo testing. This avoids the need to redesign a new implantable platform 13 
that carries the promising drug/gene; hence speeding up the process of drug development. 14 
 15 
5. Conclusion 16 
In the present study, we developed a microfiber platform for in vitro myelination study and 17 
functional screening of drugs/genes. Using miR-219 and miR-338 as the model drugs, we showed 18 
that these miRs promoted OPC differentiation on our microfiber constructs. Moreover, we also 19 
showed that the miRs promoted the ensheathment of fibers instead of the formation of flat myelin 20 
membranes. OLs transfected non-virally with miRs also possessed longer nascent myelin sheaths and 21 
more MBP+ extensions per cell. This platform could be employed for further drug/gene testing and 22 
translation into in vivo remyelination scaffold design. 23 
 18 
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Figure 1: Electrospun microfiber platform for OL functional drug testing. (A) Workflow of suspended 
microfiber substrate. (B) SEM image showed that electrospun microfiber has diameter of 2.0 ± 0.3 
μm (100 fibers were measured). (C) OPCs differentiated into OL and extended myelin-like MBP+ 
structures along the suspended fibers as shown by lines of green MBP signals. 
 
Figure 2: Scaffold-mediated delivery of miR-219/miR-338 promoted OPCs differentiation in the 
absence of mitogen. (A) Representative confocal images show that cocktail of miRs promoted 
differentiation of OPCs into MBP+ OL. (B) Quantitative data shows miR-219 and miR-338 treatment 
resulted in more MBP+ cells per DAPI. (C) Quantitative data shows miR-219 and miR-338 treatment 
resulted in more MBP+ cells per OLIG2+ cell. # indicates p < 0.05; two-tailed t test, with an average of 
more than 140 DAPI and 110 OLIG2+ cells quantified from each experimental group per experiment 
(n=3). 
 
Figure 3: Scaffold-mediated delivery of miR-219/miR-338 promoted formation of MBP+ myelin-like 
extensions on fiber instead of membrane on glass coverslip. (A) Confocal images showing formation 
of both myelin-like extensions on fiber and myelin membrane on coverglass by the same cell. (B) 
Representative confocal images show miR-219/miR-338 promoted formation of myelin-like 
wrappings around fibers. (C) Quantitative data shows miR-219 and miR-338 treatment allowed 
higher percentage of MBP+ cells to form myelin-like extensions only. * indicate p < 0.01; two-tailed t 
test, with at least 50 MBP+ cells from each group per experiment (n = 3). 
 
Figure 4: Scaffold-mediated delivery of miR-219/miR-338 increased myelin-like extension length of 
OL. (A) Representative confocal images show miR-219 and miR-338 treatment resulted in longer 
myelin-like extension length on suspended fiber platform. (B) Frequency distribution shows a shift of 
extension length distribution towards higher values when OPCs were treated with miR-219 and miR-
338. (C) Log transformation of lengths shows distribution of length of myelin-like extensions, with 
significant difference between the mean of miR-219/miR-338 and NEG miR treated group. * indicate 
p < 0.01; two-tailed t test, 196 extensions measured from 3 independent experiments. 
 
Figure 5: Scaffold-mediated delivery of miR cocktail increased number of myelin-like extensions per 
OL. (A) Representative confocal images show miR-219/miR-338 enhanced formation of more myelin-
like extensions per OL. (B) Distribution of number of myelin-like extension per OL. Quantitative data 
shows miR-219/miR-338 treatment resulted in higher average number of myelin-like extensions per 
OL. Each dot represents one cell * indicate p < 0.01; two-tailed t test, 35 cells in miR-219/miR-338 
group and 30 cells in NEG miR group, from 3 independent experiments. 
 
Supplementary figure 1: Confocal images show more than 95% pure OPCs following isolation. 
 
Figure Captions
Supplementary figure 2: SEM images of cross section of microfiber substrate. With repeated melting 
of PCL film and repeated fiber deposition, suspended fibers remained taut in layers. (A) Low 
magnification view shows fibers suspended in layers above glass coverslip. (B) Higher magnification 
view shows taut fibers. 
 
Supplementary figure 3: MBP+ wrapping on fluorescent PCL-DPP-PCL fibers. (A) Confocal image 
shows MBP signals ran along red coloured fibers. (B) 3D-reconstruction image shows MBP+ tubular 
structures surrounding red fluorescent PCL-DPP-PCL fibers. (C) 95.3 ± 1.6 % of the cells expressed 
OPCs NG2 marker 1 day post seeding. 
 
Supplementary figure 4: Video across different z-stack layers showing MBP+ extensions running 
along the fibers on both miR-219/miR-338 and NEG miR treated OPCs. 
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